Serum Institute of India

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December last year and in…

The firm has written to the Ministry of Health and Family Welfare (MoH&FW) that if these 10 crore free doses of Covishield are…

Adar Poonawalla, CEO, SII also pitched for a global pact for vaccine utilisation

It is the fourth vaccine to receive the regulator's nod for use among those below 18 years

Shipments of Nuvaxovid to additional EU member states from the company's Netherlands distribution centre are expected to quickly…

The company also requested the minister to allow it to administer Covishield’s precaution dose for all individuals aged above 18…

Serum Institute of India (SII) had sent an application to the DCGI in October for the grant of market authorisation of Covovax for…

The news comes days after Reuters reported that tens of millions of migrants may be denied COVID-19 vaccines from the…

According to WHO, Covovax was assessed under its emergency use listing procedure based on the review of data on quality, safety…

With over a billion-dollar investment that has gone into developing and manufacturing the COVID-19 vaccine, the journey, so far,…